The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-pyridyl-cyanoguanidine derivative ID: ALA190412
Cas Number: 432037-57-5
PubChem CID: 9961434
Product Number: T651316, Order Now?
Max Phase: Phase
Molecular Formula: C30H43Cl2N5O8
Molecular Weight: 637.15
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Synonyms: Teglarinad chloride | EB-1627 | EB1627 | GMX-1777 | GMX1777 | Teglarinad chloride|432037-57-5|GMX1777|Teglarinad (chloride)|EB1627|1-[[[[2-[2-[2-[2-Methoxyethoxy]ethoxy]ethoxy]ethoxy]carbonyl]oxy]methyl]-4-[N'-cyano-N''-[6-[4-chlorophenoxy]hexyl]guanidino]pyridinium chloride|GMX-1777 chloride|D6V5QYX9MZ|432037-57-5 (chloride)|GMX-1777|EB-1627|[4-[[N'-[6-(4-chlorophenoxy)hexyl]-N-cyanocarbamimidoyl]amino]pyridin-1-ium-1-yl]methyl 2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethyl carbonate chloride|UNI Show More⌵
Canonical SMILES: COCCOCCOCCOCCOC(=O)OC[n+]1ccc(N/C(=N/C#N)NCCCCCCOc2ccc(Cl)cc2)cc1.[Cl-]
Standard InChI: InChI=1S/C30H42ClN5O8.ClH/c1-38-16-17-39-18-19-40-20-21-41-22-23-43-30(37)44-25-36-13-10-27(11-14-36)35-29(34-24-32)33-12-4-2-3-5-15-42-28-8-6-26(31)7-9-28;/h6-11,13-14H,2-5,12,15-23,25H2,1H3,(H,33,34);1H
Standard InChI Key: DAHMXVAETAAQOZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
45 45 0 0 0 0 0 0 0 0999 V2000
-1.6367 -2.2171 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-1.6868 -1.0564 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.1774 -1.0397 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.8956 -1.4530 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1774 -0.2129 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8412 -1.4697 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1190 -1.0564 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.6096 -1.8580 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.4050 -1.4697 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4551 0.1962 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.8412 -2.2964 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.9728 -1.4655 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6868 -0.2171 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2588 -0.2171 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8914 0.2004 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.9728 0.1962 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2588 -1.0522 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.5552 -1.0564 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.0479 1.0522 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6200 0.2213 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7619 1.4738 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
9.0479 0.2255 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3214 1.4613 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3339 -0.1921 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6074 1.0480 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9018 -0.1921 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-13.1439 -1.0564 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-6.7014 -1.4697 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-8.8475 -1.0564 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-10.9977 -1.4697 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.6096 -0.2046 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2692 -1.4697 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1878 0.2213 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-12.4299 -1.4697 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.5615 -1.4697 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.9832 -1.0564 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-8.1335 -1.4697 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-11.7117 -1.0564 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.4153 -1.0564 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-10.2755 -1.0564 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-13.8579 -1.4697 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3236 0.2087 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4655 -0.1921 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7515 0.2129 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0376 -0.2046 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3 5 2 0
4 3 1 0
5 10 1 0
6 7 1 0
7 9 1 0
8 4 3 0
9 2 1 0
10 14 1 0
11 6 2 0
12 2 2 0
13 2 1 0
14 16 1 0
15 5 1 0
16 13 2 0
17 12 1 0
18 6 1 0
19 22 2 0
20 26 1 0
21 19 1 0
22 24 1 0
23 25 2 0
24 20 2 0
25 20 1 0
26 33 1 0
27 34 1 0
28 36 1 0
29 37 1 0
30 40 1 0
31 15 1 0
32 18 1 0
33 43 1 0
34 38 1 0
35 29 1 0
36 32 1 0
37 39 1 0
38 30 1 0
39 28 1 0
40 35 1 0
41 27 1 0
42 31 1 0
43 44 1 0
44 45 1 0
45 42 1 0
14 17 2 0
23 19 1 0
M CHG 2 1 -1 2 1
M END
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: YesAvailability: NoProdrug: Yes
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 637.15Molecular Weight (Monoisotopic): 636.2795AlogP: 3.91#Rotatable Bonds: 23Polar Surface Area: 145.77Molecular Species: NEUTRALHBA: 10HBD: 2#RO5 Violations: 1HBA (Lipinski): 13HBD (Lipinski): 2#RO5 Violations (Lipinski): 2CX Acidic pKa: ┄CX Basic pKa: 1.27CX LogP: 0.28CX LogD: 0.28Aromatic Rings: 2Heavy Atoms: 44QED Weighted: 0.03Np Likeness Score: -0.58
References 1. Binderup E, Björkling F, Hjarnaa PV, Latini S, Baltzer B, Carlsen M, Binderup L.. (2005) EB1627: a soluble prodrug of the potent anticancer cyanoguanidine CHS828., 15 (10): [PMID:15863303 ] [10.1016/j.bmcl.2005.03.064 ] 2. USP Dictionary of USAN and International Names (2010 edition) and USAN registrations 2007-date, 3. Galli U, Travelli C, Massarotti A, Fakhfouri G, Rahimian R, Tron GC, Genazzani AA.. (2013) Medicinal chemistry of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors., 56 (16): [PMID:23679915 ] [10.1021/jm4001049 ] 4. Unpublished dataset,